CHAYSE JACKSON: Open Payments
NPI 1619635067 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$665 in 30 payments from 10 companies in 2025. Trend: 2023 $959 · 2024 $937 · 2025 $665
Food & beverage: $665
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 6 | $147 |
| Regeneron Healthcare Solutions, Inc. | 5 | $114 |
| AstraZeneca Pharmaceuticals LP | 5 | $93 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $78 |
| Genentech USA, Inc. | 2 | $51 |
| Novartis Pharmaceuticals Corporation | 3 | $47 |
| GlaxoSmithKline, LLC. | 2 | $45 |
| GENZYME CORPORATION | 2 | $34 |
| Insmed, Inc. | 1 | $32 |
| Azurity Pharmaceuticals, Inc. | 1 | $24 |
Products named: DUPIXENT, ADBRY, NEFFY, AIRSUPRA, Xolair, NUCALA, TEZSPIRE, Arikayce.
Industry payments across TX — which companies pay providers there.
